Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Apr 14, 2019 2:16pm
160 Views
Post# 29624906

RE:RE:we are NOT going broke!

RE:RE:we are NOT going broke!I should also have added that if TV does insist on the full dilution now at the worst time, Lazarde should definitely look into the sale of the enrire co to some major biopharma and just payoff TV its $120 MIL AND THERE WILL STILL BE MUCH MORE LEFT FOR THE INVESTORS THAN IN FORCED DILUTION IN FAVOR OF TV.
Bullboard Posts